Journal Information
Vol. 9. Issue 4.
Pages 337-352 (July - August 2003)
Share
Share
Download PDF
More article options
Vol. 9. Issue 4.
Pages 337-352 (July - August 2003)
ARTIGO ORIGINAL/ORIGINAL ARTICLE
Open Access
Perfil epidemiológico das infecções bacterianas do aparelho respiratório em doentes com fibrose quística
Epidemiological survey of bacteria isolated from the respiratory tract of cystic fibrosis patients
Visits
4329
Sofia Quintas1, Luísa Pereira2, Luís Lito3, Celeste Barreto4
1 Interna do Internato Complementar
2 Assistente hospitalar Centro Especializado de Fibrose Quística (Coordenadora: Dra Celeste Barreto) Unidade de Pneumologia (Coordenador: Prof. J. Costa Trindade) Clínica Universitária de Pediatria (Director: Prof. J Gomes-Pedro)
3 Chefe de Serviço Laboratório de Bacteriologia (Directora: Dra Maria José Salgado)
4 Assistente graduada Hospital de Santa Maria, Av. Prof Egas Moniz, Lisboa
This item has received

Under a Creative Commons license
Article information
RESUMO

Com o intuito de caracterizar a evolução do perfil epidemiológico das infecções bacterianas do aparelho respiratório dos doentes com Fibrose Quística (FQ), os autores realizaram um estudo retrospectivo da prevalência e incidência das mesmas em 78 doentes com FQ seguidos no Centro Especializado de FQ da Clínica Universitária de Pediatria do Hospital de Santa Maria, Lisboa durante um período de 5 anos (1995-1999).

A Pseudomonas aeruginosa foi a bactéria mais frequentemente isolada nos três primeiros anos do estudo (60-73%), sendo ultrapassada nos dois anos seguintes pelo Staphylococcus aureus. No entanto, a Pseudomonas aeruginosa constituiu sempre o principal agente de colonização crónica (44-59%), com um pico de início da mesma entre os 0 e os 5 anos (34%). Verificou-se ao longo dos 5 anos um aumento significativo da prevalência de colonização intermitente e crónica por Staphylococcus aureus (48% para 83% e 32% para 54%). A prevalência de isolamentos de Staphylococcus aureus resistente à meticilina e de Burkholderia cepacia quase que duplicou neste período. As taxas de isolamento e de colonização crónica por Alcaligenes xylosoxidans aumentaram bruscamente a partir de 1997 (de 3% e 0% em 1996 para 7% e 5% em 1997 e 10% e 7% em 1999). A colonização crónica por Haemophilus influenzae manteve uma prevalência média de 22%, apesar dum aumento dos isolamentos (de 42% para 61%). Em 55% dos doentes observou-se colonização crónica por dois ou mais agentes.

Em função destes resultados são discutidos os esquemas terapêuticos e as medidas de prevenção de contágios que têm sido preconizados nos doentes com FQ do nosso centro.

REV PORT PNEUMOL 2003; IX (4): 337-352

Palavras-chave:
Fibrose Quística
bactérias
colonização crónica
pulmão
ABSTRACT

With the aim of characterizing the evolution of the epidemiological profile of respiratory bacterial infections of patients having Cystic Fibrosis (CF), the authors conducted a retrospective analysis about it’s incidence and prevalence in 78 CF patients followed at the CF Specialized Centre, Paediatric Department, Santa Maria Hospital, Lisbon, during a 5 years period (1995-1999).

Pseudomonas aeruginosa was the most frequently isolated bacteria during the first three years of the study (60-73%), being surpassed by Staphylococcus aureus. However, Pseudomonas aeruginosa always remained the principal agent of chronic colonization (44-59%), with a peak of beginning between 0 and 5 years (34%). A significative increase of the prevalence of intermitent and chronic colonization with Staphylococcus aureus was verified during this five years (48% to 83% and 32% to 54%). The prevalence of isolations of Meticillin Resistant Staphylococcus aureus and of Burkholderia cepacia almost duplicated during this period. The taxes of isolation and chronic colonization with Alcaligenes xylosoxidans raised sharply beyond 1997 (from 3% and 0% in 1996 to 7% and 5% in 1997 and 10% and 7% in 1999). Chronic colonization with Haemophilus influenzae kept a median prevalence of 22%, in spite of an increase in isolations (from 42% to 61%). Fifty five per cent of the patients were chronically colonized by two or more agents.

In view of these results, the authors discuss the therapeutic schemes and the measures to limit cross-infection which have been being advocated for CF patients in our centre.

REV PORT PNEUMOL 2003; IX (4): 337-352

Key-words:
Cystic Fibrosis
bacteria
chronic colonization
lung
Full text is only aviable in PDF
BIBLIOGRAFIA
[1.]
Mickle JE, Cutting GR. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.
[2.]
M.R. Kosorok, W.H. Wei, P.M. Farrell.
The incidence of cystic fibrosis.
[3.]
W.J. Morgan, et al.
Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the US and Canada.
Pediatr Pulmonol, 28 (1999), pp. 231-241
[4.]
G. Lenoir.
Pseudomonas aeruginosa et mucoviscidose.
Rev Pneumol Clin, 51 (1995), pp. 151-158
[5.]
M.R. Kosorok, et al.
Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition.
Pediatr Pulmonol, 32 (2001), pp. 277-287
[6.]
H.K. Johansen, T.A. Kovesi, C. Koch, M. Corey, N. Hoiby, H. Levison.
Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen.
Pediatr Pulmonol, 26 (1998), pp. 89-96
[7.]
C. Munoz.
Microbiological study of the respiratory tract in children with cystic fibrosis.
Enferm Infecc Microbiol Clin, 14 (1996), pp. 142-144
[8.]
B. Frederiksen, C. Koch, N. Hoiby.
Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995).
Pediatr Pulmonol, 28 (1999), pp. 159-166
[9.]
G. Mastella, et al.
Epidemiological survey of bacteria isolated from respiratory tract in european cystic fibrosis patients.
Abstract book,
[10.]
G. Taccetti, S. Campana.
Microbiologic data overview of Italian cystic fibrosis patients.
Eur J Epidemiol, 13 (1997), pp. 323-327
[11.]
S.C. Fitzsimmons.
The changing epidemiology of cystic fibrosis.
J Pediatr, 122 (1993), pp. 1-9
[12.]
C. Schaedel, I. De Monestrol, L. Hjelte, M. Johannesson, R. Kornfalt, A. Lindblad, et al.
Predictors of deterioration of lung function in cystic fibrosis.
Pediatr Pulmonol, 33 (2002), pp. 483-491
[13.]
P. Kubesch, T. Dork, U. Wulbrand, N. Kalin, T. Neumann, B. Wulf, et al.
Genetic determinants of airways´colonisation with Pseudomonas aeruginosa in cystic fibrosis.
Lancet, 341 (1993), pp. 189-193
[14.]
D. Hubert, T. Bienvenu, N. Desmazes-Dufeu, I. Fajac, J. Lacronique, R. Matran, et al.
Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients.
Eur Respir J, 9 (1996), pp. 2207-2214
[15.]
S. Quintas, L. Pereira, T. Bandeira, C. Barreto.
Genetic determinants of Pseudomonas aeruginosa colonization in cystic fibrosis patients,
[16.]
M.R. Kosorok, et al.
Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis.
Pediatr Pulmonol, 26 (1998), pp. 81-88
[17.]
R. Gopal, et al.
MRSA in cystic fibrosis.
Meeting report. J Hosp Infect, 40 (1998), pp. 179-191
[18.]
J. Romero-Vivas, M. Rubio, C. Fernandez, J. Picazo.
Mortality associated with nosocomial bacteriemia due to methicillin-resistant Staphylococcus aureus.
J Clin Infect Dis, 21 (1995), pp. 1417-1423
[19.]
S.R. Thomas, K.M. Gyi, H. Gaya, M.E. Hodson.
Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre.
J Hosp Infect, 40 (1998), pp. 203-209
[20.]
R. Givney, A. Vickery, A. Holliday, M. Pegler, R. Benn.
Methicillin-resistant Staphylococcus aureus in a cystic fibrosis unit.
J Hospital Infect, 35 (1997), pp. 27-36
[21.]
CUNHA MV, LEITÃO JH, Mahenthiralingam E, Vandamme P, Lito L, Barreto C et el. Molecular analysis of Burkholderia cepacia complex isolates from a portuguese cystic fibrosis center: a seven-year study. Manuscripto a aguardar publicação.
[22.]
I. Jacques, J. Derelle, M. Weber, M. Vidailhet.
Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia.
Eur J Pediatr, 157 (1998), pp. 427-431
[23.]
J.L. Burns, et al.
Microbiology of sputum from patients at cystic fibrosis centers in the united states.
Clin Infect Dis, 27 (1998), pp. 158-163
[24.]
Revets H. Burkholderia.
(Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium.
Acta Clin Belg, 51 (1996), pp. 222-230
[25.]
J.J. Lipuma.
Burkholderia cepacia. Mangement issues and new insights.
Clin Chest Med, 19 (1998), pp. 473-486
[26.]
J.J. Lipuma, K.A. Marks-Austin, D.S. Holsclaw, et al.
Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis.
Pediatr Inf Dis J, 13 (1994), pp. 716
[27.]
D.R. Burdge, E.M. Nakielna, M.A. Noble.
Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis.
Infect Control Hosp Epidemiol, 14 (1993), pp. 127-130
[28.]
C.L. Pankhurst, J. Philpott-Howard.
The environmental risk factors associated with medical and dental equipment in the transmission of Burkholderia (Pseudomonas) cepacia in cystic fibrosis patients.
J Hosp Infect, 32 (1996), pp. 249-255
[29.]
F.E. Clode, M.E. Kaufmann, H. Malnick, T.L. Pitt.
Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom.
J Clin Micobiol, 38 (2000), pp. 1763-1766
[30.]
J.J. Lipuma, T. Spielker, L.H. Gill, P.W. Campbell 3rd., L. Liu, E. Mahenthiralingam.
Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis.
Am J Resp Crit Care Med, 164 (2001), pp. 92-96
[31.]
E. Mahenthiralingam, P. Vandamme, M.E. Campbell, D.A. Henry, A.M. Gravelle, L.T. Wong, et al.
Infection with Burkholderia cepacia complex genomonovars in patients with cystic fibrosis: virulent transmissible strains of genomonovar III can replace Burkholderia multivorans.
Clin Infect Dis, 33 (2001), pp. 1469-1475
[32.]
A. Bevivino, C. Dalmastri, S. Tabacchioni, L. Chiarini, M.L. Belli, S. Piana, et al.
Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomonovar status and distribution of traits related to virulence and transmissibility.
J Clin Microbiol, 40 (2002), pp. 846-851
[33.]
C. Pereira, L. Pereira, C. Barreto.
Alcaligenes xylosoxidans colonization in cystic fibrosis.
Abstract Book,
[34.]
K. Tan, S.P. Conway, K.G. Brownlee, C. Etherington, D.G. Peckham.
Alcaligenes infection in cystic fibrosis.
Pediatr Pulmonol, 34 (2002), pp. 101-104
[35.]
C.A. Demko, R.C. Stern, C.F. Doershuk.
Stenotrophomonas maltophilia in cystic fibrosis: incidence and prevalence.
Pediatr Pulmonol, 25 (1998), pp. 304-308
[36.]
V.L. Hudson, C.L. Wielinski, W.E. Regelmann.
Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years.
J Pediatr, 122 (1993), pp. 854-860
[37.]
W.E. Regelmann, W.J. Elliott, W.J. Warwick, C.C. Clawson.
Reduction of spuntum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone.
Am Rev Resp Dis, 141 (1990), pp. 914-921
Copyright © 2003. Sociedade Portuguesa de Pneumologia/SPP
Pulmonology
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?